Valuation : Electromed, Inc.

Market Cap 228M 196M 186M 169M 316M 21.78B 318M 2.21B 849M 11.08B 856M 837M 35.01B P/E 2027 *
18.7x
P/E 2028 * 16.1x
Enterprise Value 228M 196M 186M 169M 316M 21.78B 318M 2.21B 849M 11.08B 856M 837M 35.01B EV / Sales 2027 *
2.74x
EV / Sales 2028 * 2.48x
Free-Float
82.99%
Yield 2027 *
-
Yield 2028 * -
1 day+2.25%
1 week-2.68%
Current month-2.57%
1 month-35.72%
3 months-27.55%
6 months+14.30%
Current year-6.42%
1 week 26.62
Extreme 26.62
28.04
1 month 26.62
Extreme 26.62
43.74
Current year 23.01
Extreme 23.01
47.4
1 year 23.01
Extreme 23.01
47.4
3 years 9.53
Extreme 9.53
47.4
5 years 8.75
Extreme 8.75
47.4
10 years 3.38
Extreme 3.38
47.4
Manager TitleAgeSince
Chief Executive Officer 61 30/06/2023
Director of Finance/CFO 44 13/11/2022
Compliance Officer - 31/08/2023
Director TitleAgeSince
Chairman 69 30/06/2023
Director/Board Member 76 20/11/2014
Director/Board Member 57 14/08/2019
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Free

Chief Financial Officer

15,602 0.1865%
01/09/26 Tax

Chief Executive Officer

-2,671 0.0319%
30/06/26 Tax

Chief Financial Officer

-674 0.0081%
Change 5-day change 1-year change 3-year change Capi.($)
+2.25%-2.68%+8.74%+148.18% 228M
+1.10%-0.65%+24.10%+18.43% 225B
-0.19%-3.62%+2.55%-20.00% 141B
+2.41%+0.67%-19.02%+22.09% 130B
-0.28%-10.08%-58.81%-21.22% 62.29B
-2.77%-6.15%+8.15%+12.69% 48.63B
-0.49%-1.97%-20.35%-15.53% 49.39B
+2.66%-2.61%+15.94%+29.91% 41.42B
+1.67%-0.25%+35.01%+55.09% 40.12B
-0.60%-4.41%-20.52%+44.06% 31.23B
Average +0.58%-3.35%-2.42%+27.37% 76.99B
Weighted average by Cap. +0.52%-2.50%+0.61%+9.88%

Financials

2027 *2028 *
Net sales 83.15M 71.64M 67.84M 61.49M 115M 7.94B 116M 806M 310M 4.04B 312M 305M 12.77B 92.05M 79.31M 75.1M 68.07M 128M 8.79B 128M 892M 343M 4.47B 346M 338M 14.14B
Net income 12.6M 10.86M 10.28M 9.32M 17.48M 1.2B 17.57M 122M 46.95M 612M 47.32M 46.28M 1.94B 14.75M 12.71M 12.03M 10.91M 20.46M 1.41B 20.57M 143M 54.96M 717M 55.4M 54.18M 2.27B
Net Debt - -
Logo Electromed, Inc.
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Employees
196
Date Price Change Volume
11/09/26 US$27.25 +2.25% 96,850
10/09/26 US$26.65 -1.55% 104,545
09/09/26 US$27.07 -1.60% 78,500
08/09/26 US$27.51 -1.75% 83,185
04/09/26 US$28.00 +1.41% 118,108
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
27.25USD
Average target price
48.50USD
Spread / Average Target
+77.98%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ELMD Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!